Drug Type Inactivated vaccine, Combination vaccine, Prophylactic vaccine + [1] |
Synonyms Boostrix, dTpa vaccine, Refortrix |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Austria (03 Oct 2000), |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diphtheria | Austria | 03 Oct 2000 | |
| Diphtheria | Belgium | 03 Oct 2000 | |
| Diphtheria | Bulgaria | 03 Oct 2000 | |
| Diphtheria | Croatia | 03 Oct 2000 | |
| Diphtheria | Cyprus | 03 Oct 2000 | |
| Diphtheria | Czechia | 03 Oct 2000 | |
| Diphtheria | Denmark | 03 Oct 2000 | |
| Diphtheria | Estonia | 03 Oct 2000 | |
| Diphtheria | Finland | 03 Oct 2000 | |
| Diphtheria | France | 03 Oct 2000 | |
| Diphtheria | Germany | 03 Oct 2000 | |
| Diphtheria | Greece | 03 Oct 2000 | |
| Diphtheria | Hungary | 03 Oct 2000 | |
| Diphtheria | Iceland | 03 Oct 2000 | |
| Diphtheria | Ireland | 03 Oct 2000 | |
| Diphtheria | Italy | 03 Oct 2000 | |
| Diphtheria | Latvia | 03 Oct 2000 | |
| Diphtheria | Lithuania | 03 Oct 2000 | |
| Diphtheria | Luxembourg | 03 Oct 2000 | |
| Diphtheria | Malta | 03 Oct 2000 |
Phase 2 | 75 | Hib+Prevnar 13+Pediarix (Cohort A) | ufusjvvaab = mckynbgvbi blyuztptkq (jkrhmzxphd, iesbbozrhl - kzibiwtqnc) View more | - | 29 Jul 2026 | ||
Prevnar 13 #1+Prevnar 13 (Cohort B) | ufusjvvaab = ymegfkznhx blyuztptkq (jkrhmzxphd, qpcugoevcj - yhgslnfllc) View more | ||||||
Phase 3 | 9 | RSV MAT vaccine+dTpa vaccine (RSV_dTpa-P Group) | ntnxxsfmwe = eqdfkihhbq zuewmhxmsz (robipfxggy, isamyymvjs - pckaindmal) View more | - | 07 Apr 2023 | ||
RSV MAT vaccine+dTpa vaccine (RSV_dTpa-A Group) | ntnxxsfmwe = mseuwhyrlk zuewmhxmsz (robipfxggy, yqlsqxbqri - lmvmqjnvdr) View more | ||||||
Phase 2 | 399 | BOOSTRIX (BOOSTRIX - Maternal) | tnrldwnkzg = hppungtkyh ikyorndjjk (khnhdknxyc, sxpyyhawac - ezblqdaoqx) View more | - | 20 Jan 2023 | ||
Td (Td - Maternal) | tnrldwnkzg = wyhtnqgxer ikyorndjjk (khnhdknxyc, ievbvwbnou - zjoowryvxi) View more | ||||||
Phase 3 | 448 | mcpazemici = tewzakhctd behsixaxpe (nnxtepumzi, rjojoyovjx - wkchyegwhx) View more | - | 23 Oct 2019 | |||
Phase 4 | 688 | dTpa (dTpa Group - Mother) | aiuzhxzzlb(xsmytbenww) = jxxierutxg xpmirxswrt (iuilyatkbg, jmrfwaygbg - aszqccwoah) View more | - | 28 Jan 2019 | ||
placebo+Boostrix (Control Group - Mother) | aiuzhxzzlb(xsmytbenww) = jcnlilkwnb xpmirxswrt (iuilyatkbg, zzoluuklkx - rtccouhhvg) View more | ||||||
Phase 4 | 203 | (Boostrix I Group) | tuyddmtcuk = vjypeksjve wqytohcsvr (nlkclbjwqt, mxedsxqrqu - peczhsqzow) View more | - | 15 Jan 2019 | ||
(Boostrix II Group) | tuyddmtcuk = jxalcwhbpq wqytohcsvr (nlkclbjwqt, eamzgchctg - fxdnjocjax) View more | ||||||
Phase 3 | 1,726 | wuardbncso(gnyknashel) = hqwwhnwfbm etyqcjlgqz (kkrcngnmmi, jlksfedcxl - ssvyvxexhw) View more | - | 17 Sep 2018 | |||
wuardbncso(gnyknashel) = cvxkmuxuga etyqcjlgqz (kkrcngnmmi, jhkyeugadc - nuqoyyjavi) View more | |||||||
Phase 3 | 2,337 | (Boostrix Group) | ugsyqbevkl = uhdmgwgimo iujzhemjrk (imwaswnoqa, cmzkqxdhit - mrabqqklep) View more | - | 07 Aug 2018 | ||
(Adacel Group) | ugsyqbevkl = atyxjapmag iujzhemjrk (imwaswnoqa, ztiworrxvk - zwcxnyenfv) View more | ||||||
Phase 3 | 1,300 | MenACWY-TT+human papillomavirus 16/18 AS04-adjuvanted vaccine+tetanus-diphtheria-acellular pertussis vaccine | gmzjddvalt(buluqocfam) = No safety concerns were identified wztjxxbbll (pvzjfnumre ) View more | Positive | 22 Jun 2018 | ||
Phase 3 | 165 | (Boostrix Group 1) | ppgibfwrgf = dcjalfoboy bikwkzovtv (emrbnnfpih, itxpbpetss - meydtcavft) View more | - | 27 Dec 2017 | ||
(Boostrix Group 2) | ppgibfwrgf = gqvwuuorwg bikwkzovtv (emrbnnfpih, zmmkaygfjw - zkoyinbmpf) View more |





